Position in HIMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$89,943,581
+$39,371,623 QoQ
Shares Held
2,594,277
+6.5% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 507 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 95%
Shared 5%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $2,153,058,366 across 55 Drug Manufacturers - Specialty & Generic names. HIMS ranks #9 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,542,234 | $398,264,931 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,956,873 | $269,578,854 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
430,844 | $233,444,201 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,259,717 | $212,312,700 | |
| 5 | VTRS |
Viatris Inc
|
10,038,691 | $159,414,410 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
4,256,056 | $104,741,534 | |
| 7 | ALKS |
Alkermes plc.
|
1,831,619 | $95,976,834 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
818,394 | $90,792,627 |
All Filings in HIMS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $89,943,581 | 2,594,277 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $50,571,958 | 2,436,029 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $76,889,898 | 2,368,029 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $136,987,759 | 2,415,158 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $118,788,658 | 2,382,922 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $71,969,377 | 2,435,512 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $49,283,720 | 2,038,202 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $31,854,000 | 1,729,316 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $23,580,969 | 1,167,953 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $17,946,545 | 1,160,087 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $10,475,922 | 1,177,070 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,264,439 | 1,154,919 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,287,462 | 1,094,411 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,810,814 | 1,089,800 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,791,945 | 1,059,586 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,940,918 | 1,064,681 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,886,563 | 1,078,712 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,350,125 | 253,307 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,638,030 | 250,081 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,885,322 | 250,043 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,684,465 | 154,680 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,660,457 | 125,507 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||